trending Market Intelligence /marketintelligence/en/news-insights/trending/O_w7FtKzorlgyjrnoPk11g2 content esgSubNav
In This List

Arrowhead Pharmaceuticals appoints director

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection

Video

S&P Capital IQ Pro | Powered by Advanced Visualization

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge


Arrowhead Pharmaceuticals appoints director

Arrowhead Pharmaceuticals Inc. appointed William Waddill as an independent director, effective Jan. 1, 2018.

Most recently, Waddill was senior vice president and CFO of Calithera Biosciences Inc.